Dibyadeep Datta1, Dominique Arion2, John P Corradi3, David A Lewis4. 1. Departments of Neuroscience, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Translational Neuroscience Program, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 2. Translational Neuroscience Program, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 3. Department of Applied Genomics (JPC), Bristol-Myers Squibb, New York, New York. 4. Departments of Neuroscience, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Translational Neuroscience Program, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Electronic address: lewisda@upmc.edu.
Abstract
BACKGROUND: Cognitive dysfunction in schizophrenia is associated with a lower density of dendritic spines on deep layer 3 pyramidal cells in the dorsolateral prefrontal cortex (DLPFC). These alterations appear to reflect dysregulation of the actin cytoskeleton required for spine formation and maintenance. Consistent with this idea, altered expression of genes in the cell division cycle 42 (CDC42)-CDC42 effector protein (CDC42EP) signaling pathway, a key organizer of the actin cytoskeleton, was previously reported in DLPFC gray matter from subjects with schizophrenia. We examined the integrity of the CDC42-p21-activated serine/threonine protein kinases (PAK)-LIM domain-containing serine/threonine protein kinases (LIMK) signaling pathway in schizophrenia in a layer-specific and cell type-specific fashion in DLPFC deep layer 3. METHODS: Using laser microdissection, samples of DLPFC deep layer 3 were collected from 56 matched pairs of subjects with schizophrenia and comparison subjects, and levels of CDC42-PAK-LIMK pathway messenger RNAs were measured by quantitative polymerase chain reaction. These same transcripts also were quantified by microarray in samples of individually microdissected deep layer 3 pyramidal cells from a subset of the same subjects and from monkeys exposed to antipsychotics. RESULTS: Relative to comparison subjects, CDC42EP4, LIMK1, LIMK2, ARHGDIA, and PAK3 messenger RNA levels were significantly upregulated in subjects with schizophrenia in laminar and cellular samples. In contrast, CDC42 and PAK1 messenger RNA levels were significantly downregulated specifically in deep layer 3 pyramidal cells. These differences were not attributable to psychotropic medications or other comorbid factors. CONCLUSIONS: Findings from the present and prior studies converge on synergistic alterations in CDC42 signaling pathway that could destabilize actin dynamics and produce spine deficits preferentially in deep layer 3 pyramidal cells in schizophrenia.
BACKGROUND:Cognitive dysfunction in schizophrenia is associated with a lower density of dendritic spines on deep layer 3 pyramidal cells in the dorsolateral prefrontal cortex (DLPFC). These alterations appear to reflect dysregulation of the actin cytoskeleton required for spine formation and maintenance. Consistent with this idea, altered expression of genes in the cell division cycle 42 (CDC42)-CDC42 effector protein (CDC42EP) signaling pathway, a key organizer of the actin cytoskeleton, was previously reported in DLPFC gray matter from subjects with schizophrenia. We examined the integrity of the CDC42-p21-activated serine/threonine protein kinases (PAK)-LIM domain-containing serine/threonine protein kinases (LIMK) signaling pathway in schizophrenia in a layer-specific and cell type-specific fashion in DLPFC deep layer 3. METHODS: Using laser microdissection, samples of DLPFC deep layer 3 were collected from 56 matched pairs of subjects with schizophrenia and comparison subjects, and levels of CDC42-PAK-LIMK pathway messenger RNAs were measured by quantitative polymerase chain reaction. These same transcripts also were quantified by microarray in samples of individually microdissected deep layer 3 pyramidal cells from a subset of the same subjects and from monkeys exposed to antipsychotics. RESULTS: Relative to comparison subjects, CDC42EP4, LIMK1, LIMK2, ARHGDIA, and PAK3 messenger RNA levels were significantly upregulated in subjects with schizophrenia in laminar and cellular samples. In contrast, CDC42 and PAK1 messenger RNA levels were significantly downregulated specifically in deep layer 3 pyramidal cells. These differences were not attributable to psychotropic medications or other comorbid factors. CONCLUSIONS: Findings from the present and prior studies converge on synergistic alterations in CDC42 signaling pathway that could destabilize actin dynamics and produce spine deficits preferentially in deep layer 3 pyramidal cells in schizophrenia.
Authors: Karl-Anton Dorph-Petersen; Joseph N Pierri; James M Perel; Zhuoxin Sun; Allan R Sampson; David A Lewis Journal: Neuropsychopharmacology Date: 2005-09 Impact factor: 7.853
Authors: Robert A Sweet; Joseph N Pierri; Sungyoung Auh; Allan R Sampson; David A Lewis Journal: Neuropsychopharmacology Date: 2002-12-03 Impact factor: 7.853
Authors: T Hashimoto; D Arion; T Unger; J G Maldonado-Avilés; H M Morris; D W Volk; K Mirnics; D A Lewis Journal: Mol Psychiatry Date: 2007-05-01 Impact factor: 15.992
Authors: Takanori Hashimoto; H Holly Bazmi; Karoly Mirnics; Qiang Wu; Allan R Sampson; David A Lewis Journal: Am J Psychiatry Date: 2008-02-15 Impact factor: 18.112
Authors: A L Guillozet-Bongaarts; T M Hyde; R A Dalley; M J Hawrylycz; A Henry; P R Hof; J Hohmann; A R Jones; C L Kuan; J Royall; E Shen; B Swanson; H Zeng; J E Kleinman Journal: Mol Psychiatry Date: 2013-03-26 Impact factor: 15.992
Authors: Matthew L MacDonald; Daley Favo; Megan Garver; Zhe Sun; Dominique Arion; Ying Ding; Nathan Yates; Robert A Sweet; David A Lewis Journal: Neuropsychopharmacology Date: 2018-11-02 Impact factor: 7.853
Authors: Dominique Arion; Zhiguang Huo; John F Enwright; John P Corradi; George Tseng; David A Lewis Journal: Biol Psychiatry Date: 2017-04-04 Impact factor: 13.382
Authors: Glenn T Konopaske; Darrick T Balu; Kendall T Presti; Grace Chan; Francine M Benes; Joseph T Coyle Journal: Schizophr Res Date: 2018-05-11 Impact factor: 4.939
Authors: Dibyadeep Datta; Dominique Arion; Kaitlyn M Roman; David W Volk; David A Lewis Journal: Am J Psychiatry Date: 2016-08-13 Impact factor: 18.112
Authors: M J Kim; J Biag; D M Fass; M C Lewis; Q Zhang; M Fleishman; S P Gangwar; M Machius; M Fromer; S M Purcell; S A McCarroll; G Rudenko; R T Premont; E M Scolnick; S J Haggarty Journal: Mol Psychiatry Date: 2016-07-26 Impact factor: 15.992